The company thinks it could make millions of treatment courses of remdesivir available by the end of the year if it receives FDA approval, the Gilead CEO said.
, is moving very quickly with the FDA for authorization to get the drug to patients, the CEO of the company, Gilead Sciences, said Friday., CEO Daniel O'Day told the"TODAY" show in an exclusive interview.
The company thinks it could make millions of treatment courses available by the end of the year, O'Day said. Its production capacity has already gone from 5,000 treatment courses to 100,000, he said.At the same time, Gilead and the Food and Drug Administration's collaboration"has been terrific" on possible emergency-use authorization for remdesivir as a coronavirus treatment, O'Day said.
"I expect that they're going to act very quickly," O'Day said,"and we’re prepared as a company to make sure we get this medicine to as many patients as possible as soon as possible after that approval."Sign Up
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Could Remdesivir Be the First FDA-Approved Treatment for the Coronavirus?Dr. Fauci and President Trump hope so, based on an NIAID study released Wednesday, though there are reasons to restrain optimism.
Read more »
FDA moving at 'lightning speed' on remdesivir drug as coronavirus treatmentFDA Commissioner Stephen Hahn says the agency is moving at 'lightning speed' on remdesivir but must look at 'the totality of data' before issuing emergency use authorization of the drug.
Read more »
New York Times: FDA expected to issue emergency authorization for remdesivirThe US Food and Drug Administration plans to announce an emergency-use authorization for remdesivir, an investigational coronavirus treatment, according to the New York Times
Read more »
Dr. Fauci says remdesivir trial shows drug has promise as FDA plans to announce emergency use'What it has proven is a drug can block this virus,' Fauci said Wednesday while speaking to reporters at the White House.
Read more »
Gilead CEO on remdesivir: manufacturing, pricing for coronavirus drug - Business InsiderGilead plans to spend up to $1 billion to ramp up manufacturing of its coronavirus treatment, but execs dodged Wall Street's questions about turning a profit
Read more »
FDA reportedly will approve Covid-19 treatment remdesivir, which US-funded trial shows has 'positive effect' on recovery timeNew data from a preliminary trial suggests that the drug remdesivir has a positive effect on coronavirus recovery. 'Everything that we've seen so far gives a lot of optimism and hope,' says Dr. Babafemi Taiwo, who is leading part of the study on the drug.
Read more »